Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Clinical trial NCT05424003 · RECRUITING
Trial details
- NCT number
- NCT05424003
- Sponsor
- University of Virginia
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-22
- Primary completion
- 2026-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.